Miglitol and Septic shock - a phase IV clinical study of FDA data

Summary:

Septic shock is reported as a side effect among people who take Miglitol (miglitol), especially for people who are male, 60+ old, also take Allopurinol, and have Diabetes.

The phase IV clinical study analyzes which people have Septic shock when taking Miglitol. It is created by eHealthMe based on reports of 1,515 people who have side effects when taking Miglitol from the FDA, and is updated regularly.

What is Miglitol?

Miglitol has active ingredients of miglitol. eHealthMe is studying from 1,515 Miglitol users. Check the latest studies of Miglitol.

What is Septic shock?

Septic shock (shock due to blood infection) is found to be associated with 1,746 drugs and 3,390 conditions by eHealthMe. Check the latest studies of Septic shock.

On May, 08, 2026

1,515 people reported to have side effects when taking Miglitol.
Among them, 11 people (0.73%) have Septic shock.

Among these 11 people:

What is the gender of people who have Septic shock when taking Miglitol? *

female: 9.09 %
male: 90.91 %

What is the age of people who have Septic shock when taking Miglitol? *

What are other drugs people take besides Miglitol? *

Pradaxa: 6 people, 54.55%
Losartan Potassium And Hydrochlorothiazide: 6 people, 54.55%
Allopurinol: 6 people, 54.55%
Rozerem: 5 people, 45.45%
Nesina: 5 people, 45.45%
Lipidil: 5 people, 45.45%
Opdivo: 2 people, 18.18%
Sitagliptin Phosphate: 1 person, 9.09%
Sertraline Hydrochloride: 1 person, 9.09%
Pantethine: 1 person, 9.09%

What are other side effects people have besides Septic shock? *

Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 6 people, 54.55%
Necrotising Colitis (inflammation in the intestines (usually the colon) that can be life-threatening): 6 people, 54.55%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 4 people, 36.36%
Hepatic Function Abnormal: 3 people, 27.27%
Urinary Tract Infection: 2 people, 18.18%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 18.18%
Aplastic Anemia: 2 people, 18.18%
Blast Cells Present: 2 people, 18.18%
Cellulitis (infection under the skin): 2 people, 18.18%
Thyroid Diseases: 2 people, 18.18%

What are the existing conditions these people have? *

Diabetes: 7 people, 63.64%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 54.55%
Insomnia (sleeplessness): 5 people, 45.45%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 5 people, 45.45%
Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 45.45%
High Blood Pressure: 5 people, 45.45%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 5 people, 45.45%
Hepatic Function Abnormal: 2 people, 18.18%
Gastric Cancer (stomach cancer): 2 people, 18.18%
Metastases To Bone (cancer spreads to bone): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Miglitol and have Septic shock?

- Check whether Septic shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Miglitol:

Miglitol (1,515 reports)

Septic shock treatments and more:

Septic shock (51,128 reports)

Browse all side effects of Miglitol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Septic shock:

Septic shock (1,746 drugs)

Browse all the conditions that are associated with Septic shock:

Septic shock (3,390 conditions)

Related publications that referenced our studies

Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .

How the study uses the data?

The study uses data from the FDA. It is based on miglitol (the active ingredients of Miglitol) and Miglitol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.